Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
580 trials across Europe, recruiting first
MV140 for Women with Recurrent Uncomplicated Urinary Tract Infections
PortugalAvelumab Maintenance in Patients with Metastatic Urothelial Carcinoma After Second-Line Platinum-Based Chemotherapy
ItalyStudy of Empagliflozin, Losartan Potassium and Hydrochlorothiazide to Prevent Kidney Stones in Patients with Paraffin Oil Induced Granulomatous Disease
DenmarkPrevention of acute kidney injury after cardiac surgery in infants and neonates using carperitide (HANP injection 1000) – randomized controlled trial
SwedenREGN10597 Alone or with Cemiplimab in Adults with Advanced Solid Tumours, Melanoma, or Clear-Cell Renal-Cell Carcinoma
FranceAcetylsalicylic Acid for Preventing Preeclampsia in Pregnant Women
SpainOM336 for Desensitization in Patients with End-Stage Renal Failure Awaiting Kidney Transplantation
AustriaA study of pembrolizumab, belzutifan, and lenvatinib before main treatment in patients with localized kidney cancer
SpainA study to evaluate the effect of survodutide on protein levels in the urine for patients with chronic kidney disease
GermanyA study to evaluate the safety and tolerability of azathioprine in patients with autosomal dominant polycystic kidney and liver disease
BelgiumStudy of methenamine hippurate compared to a drug combination for preventing recurrent urinary tract infections in women
SpainA study to evaluate the safety and effectiveness of urokinase, catalytic domain, fused with a single-chain antibody against von Willebrand factor in patients with immune-mediated thrombotic thrombocytopenic purpura.
FranceThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
